Agios Pharmaceuticals, Inc.
AGIO
$33.51
$0.922.82%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -100.70M | -99.11M | -108.04M | -103.43M | -112.02M |
| Total Depreciation and Amortization | 1.35M | 1.36M | 1.27M | 1.37M | 1.26M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 43.07M | 17.63M | 15.15M | 14.14M | 25.35M |
| Change in Net Operating Assets | -1.03M | -38.80M | -4.59M | -231.00K | 8.28M |
| Cash from Operations | -57.31M | -118.92M | -96.21M | -88.15M | -77.12M |
| Capital Expenditure | -1.21M | -769.00K | -1.12M | -1.56M | -875.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 41.42M | 142.08M | 91.20M | 97.11M | 79.84M |
| Cash from Investing | 40.21M | 141.31M | 90.08M | 95.56M | 78.97M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.15M | 2.08M | 2.56M | 4.44M | 65.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.15M | 2.08M | 2.56M | 4.44M | 65.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -13.95M | 24.47M | -3.58M | 11.84M | 1.91M |